Revvity Inc.
USUSDRevvity Inc. (LSE:0KHE) — Biotechnology: Laboratory Analytical Instruments. Liczba giełd, na których notowane są akcje spółki: 3. Na tej stronie — cena i wykres, dywidendy, najwięksi akcjonariusze oraz historia liczby akcji.
O Firmie
- Strona
- revvity.com
- Relacje Inwestorskie
- ir.revvity.com/home/default.aspx
- Sektor
- Industrials · Biotechnology: Laboratory Analytical Instruments
- Siedziba
- Waltham, United States
- Prezes
- Prahlad R. Singh
- Pracownicy
- 11 000
- Akcje w Obrocie
- 111.59 mln na 2026-08-06
- Free Float
- 102.49 mln
- Kapitalizacja Rynkowa
- 16.63 mld USD
- Insiderzy
- 0.26%
- Inwestorzy Instytucjonalni
- 96.55%
- Branża (SIC)
- Laboratory Analytical Instruments
- Forma Prawna
- ZJTK
- LEI
- 549300IKL1SDPFI7N655
- P/E
- 71.1
- Stopa Wypłaty
- 13.4%
- FCF
- 558 mln USD
- Wypłaty / FCF
- 6%
- Dług
- 3.21 mld USD3.9 l. FCF
- Staż Dywidendowy
- 43 l.
- Zysk, FCF i wypłacone dywidendy — za 12 miesięcy do 05.07.2026 (najnowszy raport spółki).
- NAV
Opis
Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents, assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. The company also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, chemagic, Chitas, CNGnome, DELFIA, DELFIA Xpress, EONIS, EUROArray , EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, GSP, Haoyuan, IDS Immunodiagnosticsystems, IDS-i10, IDS-i10T, IDS-i20, IDS-iSYS, iLab, iQ, LifeCycle, LimsLink, Migele, NeoBase, NeoLSD, NEXTFLEX, Panthera Puncher, PreNAT II, Prime, RONIA, SimplicityChrom, Specimen Gate, Superflex, Symbio, T-SPOT, Vanadis, ViaCord, VICTOR2, and WholePanel brand names, as well as under the Accell, AlphaLISA, AlphaPlex, AlphaScreen, Alpha SureFire, AssayMate, BIOCHIPs, BioLegend, Bioo Scientific, BioQule, Brilliant Violet, Ce3D, CellCarrier, Cellaca, Celigo, Cellometer, cell::explorer, Cell-Vive, Chalice, ChemDraw, CHOSOURCE, Dharmacon, and DharmaFECT brand names. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
Dywidendy
Revvity Inc. (RVTY) wypłaca dywidendy kwartalnie. Za rok (12 miesięcy do ostatniej ogłoszonej wypłaty włącznie): 0.28 USD na akcję (wypłat: 4). To około 0.18% obecnej ceny akcji. Na podstawie historii wypłat następna data ex-dywidendy spodziewana jest około 22.01.2027. Lata nieprzerwanych dywidend: 43.
| Dzień Ex | Wypłata | Kwota | % | Typ | Ticker |
|---|---|---|---|---|---|
| 2026-10-23 | 2026-11-13 | 0.0700 USD | 0.0/0.2 % | kwartalnie | US:RVTY |
| 2026-07-17 | 2026-08-07 | 0.0700 USD | 0.1/0.3 % | kwartalnie | US:RVTY |
| 2026-04-17 | 2026-05-08 | 0.0700 USD | 0.1/0.3 % | kwartalnie | US:RVTY |
| 2026-01-16 | 2026-02-06 | 0.0700 USD | 0.1/0.2 % | kwartalnie | US:RVTY |
| 2025-10-17 | 2025-11-07 | 0.0700 USD | 0.1/0.3 % | kwartalnie | US:RVTY |
| 2025-07-18 | 2025-08-08 | 0.0700 USD | 0.1/0.3 % | kwartalnie | US:RVTY |
| 2025-04-17 | 2025-05-09 | 0.0700 USD | 0.1/0.3 % | kwartalnie | US:RVTY |
| 2025-01-17 | 2025-02-07 | 0.0700 USD | 0.1/0.2 % | kwartalnie | US:RVTY |
| 2024-10-18 | 2024-11-08 | 0.0700 USD | 0.1/0.2 % | kwartalnie | US:RVTY |
| 2024-07-19 | 2024-08-09 | 0.0700 USD | 0.0/0.2 % | kwartalnie | US:RVTY |
| 2024-04-18 | 2024-05-10 | 0.0700 USD | 0.0/≈0.2 % | kwartalnie | US:RVTY |
| 2024-01-18 | 2024-02-09 | 0.0700 USD | 0.0/≈0.2 % | kwartalnie | US:RVTY |
| 2023-10-19 | 2023-11-10 | 0.0700 USD | 0.0/≈0.2 % | kwartalnie | US:RVTY |
Wiadomości w Tym Tygodniu
Komunikaty prasowe ze strony firmy dla inwestorów, aktualizowane codziennie. Linki prowadzą na stronę firmy. Nagłówki są w oryginalnym języku, jak na stronie internetowej firmy.
Najwięksi Akcjonariusze
| Posiadacz | Udział | Akcje | Data Raportu |
|---|---|---|---|
| T. Rowe Price Investment… | 16.37% | 18.26 mln | 2026-06-30 |
| T. ROWE PRICE CAPITAL AP… | 10.2% | 11.38 mln | 2026-06-30 |
| Jupiter Topco LLC | 7.74% | 8.64 mln | 2026-06-30 |
| Edgepoint Investment Gro… | 7.66% | 8.54 mln | 2026-06-30 |
| Blackrock Inc. | 6.86% | 7.66 mln | 2026-06-30 |
| Vanguard Capital Managem… | 6.54% | 7.3 mln | 2026-06-30 |
| JANUS INVESTMENT FUND-Ja… | 5.15% | 5.75 mln | 2026-06-30 |
| Price (T.Rowe) Associate… | 4.96% | 5.53 mln | 2026-06-30 |
| Vanguard Portfolio Manag… | 4.28% | 4.77 mln | 2026-06-30 |
| State Street Corporation | 3.89% | 4.34 mln | 2026-06-30 |
| Victory Capital Manageme… | 3.27% | 3.65 mln | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 3.18% | 3.55 mln | 2026-06-30 |
| Dimensional Fund Advisor… | 3.07% | 3.43 mln | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.59% | 2.89 mln | 2026-06-30 |
| -Price (T.Rowe) U.S. Val… | 2.41% | 2.69 mln | 2026-06-30 |
| TR PRICE-Price (T.Rowe)… | 2.41% | 2.69 mln | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.29% | 2.56 mln | 2026-06-30 |
| JNL Series Trust-JNL/T.… | 2.27% | 2.53 mln | 2026-06-30 |
| Victory Portfolios-Victo… | 2.12% | 2.37 mln | 2026-06-30 |
| T. Rowe Price Value Fund… | 1.93% | 2.16 mln | 2026-06-30 |
| Invesco Exchange-Traded… | 1.67% | 1.87 mln | 2026-08-31 |
| SINGH PRAHLAD R (Chief E… | ≈0.09% | 105 676 | 2026-08-13 |
| GOLDBERG JOEL S (General… | ≈0.09% | 105 223 | 2026-08-14 |
| BARRETT PETER (Director) | ≈0.03% | 28 293 | 2026-05-07 |
| WITNEY FRANKLIN R. PH.D.… | ≈0.02% | 23 354 | 2026-05-07 |
| CHAPIN SAMUEL R. (Direct… | ≈0.02% | 22 676 | 2026-05-07 |
| VICTOR MIRIAME (Officer) | ≈0.02% | 18 122 | 2026-02-24 |
| WITZ PASCALE (Director) | ≈0.01% | 15 985 | 2026-05-07 |
| KRAKOWIAK MAXWELL (Chief… | ≈0.01% | 14 781 | 2026-09-21 |
| MICHAS ALEXANDROS P (Dir… | — | — | 2026-08-25 |
| MICHAS ALEXIS P (Directo… | — | — | 2025-08-27 |
